New FMI Report Explores Impact of COVID 19 Outbreak on Muscle Stimulation Device

Posted by aliena on February 2nd, 2021

The global muscle stimulation devices market is slated to grow passively, at a 3.9% CAGR during 2018-2028. Rising incidences of spinal cord and head injuries is likely to boost growth of the global market during the assessment period. Furthermore, higher number of fitness enthusiasts and athletes use electrical muscle stimulators to improve their training regimens and fitness. These devices are also utilized in home care settings and gyms to amplify exercise programs.

“Combination therapy using MS, US, and IFT devices are trending the Asia Pacific market, particularly for lower back pain and joint pain. Thus, several companies in APAC are projected to target physiotherapy clinics and hospitals, for expanding portable combination device sales.” states the FMI analyst.

Request a report sample to gain comprehensive market insights at https://www.futuremarketinsights.com/reports/sample/rep-gb-1140

Important Highlights

• The US in North America market is spearheading the global market followed by Europe.
• Transcutaneous Electric Nerve Stimulator (TENS) will lead among other product types in the global market
• Pain management application is anticipated to expand a notable pace due to rising geriatric population suffering from muscle pain.
• Physiotherapy clinics will record high CAGR amid the forecast period in contrast to other end users.

 Drivers

• Launch of technologically advanced products, for instance, wearable muscle stimulator devices will push market growth in the forthcoming years.
• Increasing preference for muscle stimulator amid physiotherapists is supporting growth in the market.
• Increasing cases of Anterior Cruciate Ligament (ACL) tear, hamstring strain and hip flexor strain, amid sports players which necessitates muscle stimulation therapy is likely to impel the growth.

Restraints

• Higher cost associated with the muscle stimulator is encouraging consumers to choose for cheaper substitute therapies.
• Increased adoption of alternative therapies amid patient population due to absence of guidelines for the usage is restraining the market growth.

COVID-19 Impact on Muscle Stimulation Devices Market

The need for lifesaving medical devices is unlike anything the healthcare sector with the onset of COVID-19 pandemic. The muscle stimulation devices market is foreseeing a notable surge in demand as notably large number of patients with COVID-19 necessitates long ICU admission and longer stays are likely to develop ICU-acquired weakness.

Competitive Landscape

Key players in the muscle stimulation devices market are fortifying product portfolio by presenting new products with enhanced features, and via strategic m&a. Furthermore, a rising number of local players will result in forming a fragmented market, as the market is already led by smaller-sized companies fulfilling the domestic consumer demands.

Some of the players identified in the global market are Omron Corporation, R.S. Medical Inc., Neurometrix Inc., Zynex Inc., and DJO Global Inc.